Human polynucleotide kinase-phosphatase (PNKP) is identified as a key enzyme involved in DNA repair following damage by IR or topoisomerase I inhibitors (e.g. irinotecan) in many types of cancer including CRC (23–26). The gene discussed is PNKP; the disease is colorectal carcinoma.